2012-11-16 16:18:49 -
Cell culture market to increase at a CAGR of 9.3%
The global cell culture market has been forecast to increase at a compound annual growth rate (CAGR) of 9.3% over the next six years, increasing from a value of $3.4 billion in 2011, to hit a market value of $6.3 billion in 2018.The cell culture market is growing continuously due to increased demand for biopharmaceutical products. The introduction of biosimilars across various geographies in the forecast period on a large scale will boost the cell culture market, rapidly. Despite concerns about low flexibility for manufacturing quantities and other factors, the higher efficacy of the end products will drive its growth in the future.The growth in biopharmaceuticals is creating an unprecedented increase in demand for cell culture products. Cell culture techniques
have been used in biological sciences for more than 50 years; however, cell culture techniques have been applied to production systems for only the last 26 years or so. The cell culture industry, which began in the late 1980s from the utilisation of recombinant DNA technology and cell hybridisation, is today a major underpinning of the biopharmaceutical market.The development of recombinant methods involves genetic manipulation and restructuring of DNA or genes. Genetic recombination usually takes place in a biological environment, while DNA recombination occurs either during a repair response or experiments using in vitro studies.This is also known as genetic engineering technology and was developed at the end of the twentieth century. This method was further developed for large-scale cell culture production and was found to be helpful in protein synthesis processes, such as insulin production.The cell culture market has more than 90% of its products manufactured by a small number of players, including EMD Millipore, Life Technologies Corporation, Sigma-Aldrich Corporation and Thermo Fisher Scientific Inc. A significant number of small players are also entering into the market, especially in emerging countries. However, tough industry regulations limit the speed at which these companies can progress.The introduction of biosimilars across various geographies on a large scale through to 2018, will boost the cell culture market, rapidly. Despite concerns about low flexibility for manufacturing quantities and other factors, the higher efficacy of the end products will drive its growth in the future.For more information on the cell culture market, see the latest research: Cell Culture MarketFollow us on Twitter @CandMResearch
Click for news details:
www.companiesandmarkets.com/News/Healthcare-and-Medical/Cell-cul ..
Browse all Healthcare and Medical C&M News
www.companiesandmarkets.com/News/Healthcare-and-Medical/?aCode=f ..
About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.comâs online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.
